Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma

Our data support the notion that HCV-related lipid metabolic abnormalities may contribute to hepatic steatosis and the development of cancer. Identification of these aberrations would stratify patients and improve treatment algorithms.